PRTN3 and rheumatoid arthritis: The fact that ACPA are present in a similar percentage of African patients as previously reported in European patients despite a major difference in the proportion of SE-positive patients, suggests that other non-HLA genetic factors contribute to the development of RA and of these autoantibodies in African RA patients.